Tramadol Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 82804-298

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 82804-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-298-30 (Image 01)

Label for Tramadol HCl 100 mg extended-release (ER) tablets, once daily, quantity 30. The label includes dosage form as film-coated tablets, imprint details, manufacturer Macleods Pharmaceuticals Ltd, and packaging by Proficient Rx LP. It features a barcode, QR codes, controlled substance schedule C-IV, NDC 82804-298-30, and storage instructions.*

FDA Label Image

505 (Tramadol Figure 1 A)

Line graph showing Tramadol concentration (ng/mL) over time (hours) for two formulations: Tramadol HCl Extended-Release Tablets 200 mg once daily (solid circles) and Tramadol HCl Tablets 50 mg every 6 hours (open circles). The graph compares drug concentration profiles over a 24-hour period.*

FDA Label Image

505 (Tramadol Figure 1 B)

A line graph comparing plasma M1 metabolite concentration (ng/mL) over time (hours) between Tramadol Hydrochloride extended-release tablets 200 mg once daily and Tramadol Hydrochloride tablets 50 mg every 6 hours. The y-axis shows M1 concentration, and the x-axis shows time from 0 to 24 hours.*

FDA Label Image

65 (Tramadol Figure 2)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis.' It depicts percent of patients achieving response on the Y-axis versus response threshold (percent improvement from baseline) on the X-axis, comparing different strengths of tramadol hydrochloride extended-release tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo.*

FDA Label Image

565 (Tramadol Figure 3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis.' It shows the percent of patients achieving response on the y-axis and response threshold as percent improvement from baseline on the x-axis, comparing Tramadol Hydrochloride Extended-Release Tablets to placebo.*

FDA Label Image

Str (Tramadol Str)

Chemical structure of Tramadol Hydrochloride, illustrating the arrangement of atoms and bonds including the aromatic ring, methoxy group, and hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.